TRIM63 and cardiomyopathy: Therefore, we measured the amount of O-GlcNAc proteins in MuRF2−/− heart, hypothesizing that the loss of MuRF2 cleared fewer O-GlcNAc-modified proteins, to mediate the enhanced cardiomyopathy seen in vivo.